XEBRA BRANDS LTD - XBRAF STOCK NEWS

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announced the results of its Annual General and Special Meeting held on August 26, 2022. Shareholders elected five new directors: Antonio Grimaldo, Jay Garnett, Jordi Chemonte, Robert Giustra, and Todd Dalotto. The election saw a high approval rate, with the director nominees receiving over 99% approval. All proposed resolutions were also approved by the shareholders. Detailed voting results indicate significant shareholder engagement, with a non-vote count of 3,622,735.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has launched its Vicious Citrus cannabis-infused lemonade in Ontario, Canada, with plans for rapid expansion across the country. The beverage features a 5:1 THC/CBN ratio, including 10mg of THC and 2mg of CBN, a cannabinoid gaining popularity. Over 1,300 cannabis retailers in Ontario can place orders via the Ontario Cannabis Store. Initial retailer feedback and demand indicate strong sell-through, prompting Xebra to increase production to meet anticipated demand.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has successfully completed its first commercial production of Vicious Citrus cannabis-infused lemonade. The product will be available in Canada, starting with an initial order of 10,500 units for Ontario. Vicious Citrus features a 5:1 THC to CBN ratio, combining 10mg of THC with 2mg of CBN. Xebra plans to launch additional beverages later this year and is exploring opportunities for expansion into international markets. This milestone is viewed as significant for the company's beverage segment growth.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has updated its corporate strategy, opting to exit Colombia and the Netherlands to focus on Mexico and Canada. This decision aligns with their goal of establishing a dominant market position in low-cost cannabis cultivation and product manufacturing. In Canada, Xebra is launching its Vicious Citrus cannabis-infused lemonades, which include unique cannabinoid formulations. In Mexico, the company awaits formal cannabis authorizations to commence commercial activities following a Supreme Court injunction. This strategic shift aims to enhance shareholder value.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has appointed Jay Garnett as its new CEO and Director. Garnett is a seasoned entrepreneur with a notable track record in consumer-packaged goods, having founded Seattle's Best Coffee Canada, which was later acquired by Starbucks. He led the Healthy Beverage Company, known for its category-leading organic teas, and participated in the successful growth of Spud.com, which reported $132.8 million in revenue in 2021. Garnett expressed his excitement about launching Xebra’s first commercial cannabis product, Vicious Citrus, targeting key market positions.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) announces that its Vicious Citrus cannabis-infused lemonade has been accepted by the Ontario Cannabis Store (OCS) for sale in Ontario, Canada. This beverage combines 10mg of THC with 2mg of CBN and is among the few Canadian products containing CBN. Marketing efforts will commence ahead of its commercial production scheduled for June 20, with availability expected in summer 2022. Xebra's lemonade is noted for its emulsion technology, which underwent Phase I clinical trials, highlighting its commitment to product safety and quality.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announced the successful closing of its oversubscribed non-brokered private placement, raising C$1,800,000 through the issuance of 15,000,000 units priced at C$0.12 each. Each unit includes one common share and a half warrant, with full warrants allowing the purchase of a share at C$0.25 for 12 months. The company will use proceeds for general working capital.

The private placement is subject to a hold period expiring on August 9, 2022.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has successfully harvested its first cannabis crop in the Netherlands, comprised of high THC and THC-CBD balanced flowers. The samples were submitted to the Bureau of Medicinal Cannabis on March 25, 2022. As one of five companies selected for a Dutch government pilot trial, Xebra aims to secure one of two licenses, potentially generating at least ~US$80 million in guaranteed revenue. Further crops are planned for submission, with the next deadline set for September 19, 2022, and a decision on licenses expected by April 3, 2023.

Xebra Brands Ltd. (CSE: XBRA) has secured a significant milestone with the Supreme Court of Mexico issuing a final resolution granting an injunction to its subsidiary, Desart MX, SA de CV. This decision solidifies Xebra's first-mover advantage in the emerging Mexican cannabis market, particularly in the industrial cannabis sector, focusing on low-THC products. Following previous unanimous support from the Supreme Court, the company aims to initiate formal cannabis operations within 2022, leveraging Mexico's potential as a major cannabis consumer market and its favorable manufacturing costs compared to North America.